BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31112375)

  • 1. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
    Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
    Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
    Chun K; Wenger GD; Chaubey A; Dash DP; Kanagal-Shamanna R; Kantarci S; Kolhe R; Van Dyke DL; Wang L; Wolff DJ; Miron PM
    Cancer Genet; 2018 Dec; 228-229():236-250. PubMed ID: 30554732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
    Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
    Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of FISH combined with Morphology, Immunophenotype and Cytogenetic Analysis of Childhood/ Adult Acute Lymphoblastic Leukemia in Omani Patients.
    Goud TM; Al Salmani KK; Al Harasi SM; Al Musalhi M; Wasifuddin SM; Rajab A
    Asian Pac J Cancer Prev; 2015; 16(16):7343-50. PubMed ID: 26514535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia.
    Simons A; Stevens-Kroef M; El Idrissi-Zaynoun N; van Gessel S; Weghuis DO; van den Berg E; Waanders E; Hoogerbrugge P; Kuiper R; van Kessel AG
    Genes Chromosomes Cancer; 2011 Dec; 50(12):969-81. PubMed ID: 21882283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics in pre-B and B-cell acute lymphoblastic leukemia: a study of 208 patients diagnosed between 1981 and 2008.
    De Braekeleer E; Basinko A; Douet-Guilbert N; Morel F; Le Bris MJ; Berthou C; Morice P; FĂ©rec C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Jul; 200(1):8-15. PubMed ID: 20513528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
    Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
    Xu X; Bryke C; Sukhanova M; Huxley E; Dash DP; Dixon-Mciver A; Fang M; Griepp PT; Hodge JC; Iqbal A; Jeffries S; Kanagal-Shamanna R; Quintero-Rivera F; Shetty S; Slovak ML; Yenamandra A; Lennon PA; Raca G
    Cancer Genet; 2018 Dec; 228-229():218-235. PubMed ID: 30344013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia].
    Kim SR; Kim HJ; Kim SH
    Korean J Lab Med; 2009 Oct; 29(5):371-8. PubMed ID: 19893343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasias.
    Verdorfer I; Brecevic L; Saul W; Schenker B; Kirsch M; Trautmann U; Helm G; Gramatzki M; Gebhart E
    Cancer Genet Cytogenet; 2001 Jan; 124(1):1-6. PubMed ID: 11165314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH.
    Kotkowska A; Wawrzyniak E; Blonski JZ; Robak T; Korycka-Wolowiec A
    Leuk Res; 2011 Aug; 35(8):1032-8. PubMed ID: 21333354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
    Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
    Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.